New CRISPR-based gene therapy effectively targets cancer-causing ‘fusion genes’ and improves survival in mouse models of aggressive cancers, researchers report.
New CRISPR-based gene therapy effectively targets cancer-causing ‘fusion genes’ and improves survival in mouse models of aggressive cancers, researchers report.